Compare IKT & HFFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IKT | HFFG |
|---|---|---|
| Founded | 2008 | 1997 |
| Country | United States | United States |
| Employees | N/A | 960 |
| Industry | Biotechnology: Pharmaceutical Preparations | Food Distributors |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 220.5M | 97.8M |
| IPO Year | 2020 | 2016 |
| Metric | IKT | HFFG |
|---|---|---|
| Price | $2.33 | $1.56 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $5.00 | ★ $6.00 |
| AVG Volume (30 Days) | ★ 355.2K | 70.4K |
| Earning Date | 03-26-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 57.76 | 20.65 |
| EPS | N/A | ★ 0.07 |
| Revenue | N/A | ★ $1,228,282,000.00 |
| Revenue This Year | N/A | $5.59 |
| Revenue Next Year | N/A | $2.24 |
| P/E Ratio | ★ N/A | $21.57 |
| Revenue Growth | N/A | ★ 2.21 |
| 52 Week Low | $1.33 | $1.38 |
| 52 Week High | $2.61 | $3.46 |
| Indicator | IKT | HFFG |
|---|---|---|
| Relative Strength Index (RSI) | 46.75 | 29.23 |
| Support Level | $2.29 | $1.40 |
| Resistance Level | $2.31 | $1.97 |
| Average True Range (ATR) | 0.10 | 0.07 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 26.51 | 14.86 |
Inhibikase Therapeutics Inc a clinical-stage pharmaceutical company developing therapeutics to modify the course of cardiopulmonary diseases, namely, Pulmonary Arterial Hypertension (PAH), in which aberrant signaling through type III receptor tyrosine kinases, including platelet derived growth factor receptors and a stem cell factor receptor, known as c-Kit, has been implicated. Its product candidate is IKT-001, a prodrug of imatinib mesylate (imatinib), for PAH which is an orphan indication. The company has developed its own portfolio of protein kinase inhibitors to treat bacterial and viral infections, including viral infections in the brain. It has one reporting segment, which is the business of developing protein kinase inhibitor therapeutics.
HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, frozen and dry food, and non-food products to Asian restaurants and other foodservice customers throughout the United States. The company's business consists of one operating segment: HF Group, which operates solely in the United States. The company's product list consists of Meat, Poultry & Seafood, Sauces & Oils, Takeout Items (Boxes, Chopsticks & Utensils), Raw Ingredients (Flour, Cornstarch, Spices), Cleaning Supplies, and Rice & Grains.